75907-432-01 : NDC 2026 Code

75907-432-01 : Acetaminophen Aspirin Caffeine ( Acetaminophen Aspirin Caffeine )

Additionally :

You can get information about “75907-432-01” NDC code in 75907-432-01 in HTML format

HTML | 75907-432-01 in TXT (Plain Text) format

TXT | 75907-432-01 in PDF (Portable Document Format)

PDF | 75907-432-01 in XML format

XML formats.

NDC Code : 75907-432-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "75907-432-01",
    "PackageDescription": "1 BOTTLE in 1 CARTON (75907-432-01)  / 100 TABLET in 1 BOTTLE",
    "NDC11Code": "75907-0432-01",
    "ProductNDC": "75907-432",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Acetaminophen Aspirin Caffeine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen Aspirin Caffeine",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260925",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA214039",
    "LabelerName": "Dr. Reddy&#39;s Laboratories Inc.",
    "SubstanceName": "ACETAMINOPHEN; CAFFEINE; ASPIRIN",
    "StrengthNumber": "250; 65; 250",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-09-26",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260925",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}